BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 6:30:39 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-11-11 11:52 |
|
Peer-Review Started |
|
2025-11-12 00:23 |
|
First Decision by Editorial Office Director |
|
2025-11-24 12:38 |
|
Return for Revision |
|
2025-11-24 12:38 |
|
Revised |
|
2025-12-01 16:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-24 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-24 10:44 |
|
Articles in Press |
|
2025-12-24 10:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-29 10:16 |
|
Publish the Manuscript Online |
|
2026-02-06 06:30 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chuang Cai, Jin-Man Chen, Zu-Xun Qiu and Shu-Qi Ren |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhongshan Science and Technology Bureau |
2023B1033 |
|
| Corresponding Author |
Shu-Qi Ren, Associate Research Scientist, Department of Laboratory Medicine, Zhongshan Integrated Traditional Chinese and Western Medicine Hospital, No. 10 Dexiu Road, Zhongshan 528467, Guangdong Province, China. shuchijen@163.com |
| Key Words |
Claudin-6; High-grade endometrial carcinoma; Risk stratification; Therapeutic target; Prognosis |
| Core Tip |
This editorial focuses on the expression and clinical importance of the tight junction protein claudin-6 (CLDN6) in high-grade endometrial carcinoma. It demonstrates that CLDN6 overexpression independently correlates with aggressive pathological characteristics and poor patient outcomes. These findings underscore CLDN6’s value as a prognostic biomarker and highlight its potential as a therapeutic target, opening new possibilities for improved risk stratification and personalized treatment strategies in high-grade endometrial carcinoma. |
| Publish Date |
2026-02-06 06:30 |
| Citation |
Cai C, Chen JM, Qiu ZX, Ren SQ. Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies. World J Clin Oncol 2026; 17(2): 116390 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i2/116390.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i2.116390 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
